{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:57:05Z","timestamp":1784228225147,"version":"3.55.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Unplanned healthcare utilization events, including hospital readmissions and emergency room visits, are common in patients receiving outpatient parenteral antimicrobial therapy (OPAT). Little is known about patient adherence to therapy in this setting. This clinical trial evaluates the impact of a remote therapeutic monitoring (RTM) device with an integrated care platform on all-cause healthcare utilization in patients on OPAT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective, open-label, nonrandomized study enrolled patients discharged on OPAT to receive the IV Ensure RTM device compared to contemporaneous controls. The primary outcome was all-cause healthcare utilization, including hospital readmission or emergency room visit, assessed at day 90 after discharge. Adherence to antimicrobial therapy was evaluated in the intervention group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 81 patients were enrolled in the intervention group, with 131 patients in the control group. Both groups had similar baseline and OPAT characteristics. On multivariate Cox regression analysis, the RTM intervention was associated with a 39% reduction in all-cause healthcare utilization by day 60 (adjusted hazard ratio, 0.61 [95% confidence interval, .38\u2013.96]; P = .03]) and a 38% reduction by day 90 (0.62 [.40\u2013.95]; P = .03). In the intervention group, the overall adherence reached a median of 94%, and 61.7% of patients maintained adherence of &amp;gt;90% throughout their OPAT course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An RTM device with an integrated care platform significantly reduced all-cause healthcare utilization events in patients on OPAT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciag009","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:28:38Z","timestamp":1767702518000},"page":"e899-e909","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of a Remote Therapeutic Monitoring Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4282-4134","authenticated-orcid":false,"given":"Emily A","family":"Siegrist","sequence":"first","affiliation":[{"name":"Department of Pharmacy, OU Health , Oklahoma City, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9738-5165","authenticated-orcid":false,"given":"Mitchell","family":"Berenson","sequence":"additional","affiliation":[{"name":"IV Ensure, Inc , Dallas, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin D","family":"Dvorak","sequence":"additional","affiliation":[{"name":"Hudson College of Public Health, University of Oklahoma Health Campus , Oklahoma City, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob K","family":"Dozier","sequence":"additional","affiliation":[{"name":"IV Ensure, Inc , Dallas, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Rae","family":"Wannier","sequence":"additional","affiliation":[{"name":"IV Ensure, Inc , Dallas, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Wilson","family":"Dib","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Oklahoma Health Campus , Oklahoma City, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M","family":"Scott","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Oklahoma Health Campus , Oklahoma City, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7324-8670","authenticated-orcid":false,"given":"Nayle","family":"Ibragimova","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, OU Health , Oklahoma City, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5027-2931","authenticated-orcid":false,"given":"Debbie Nail","family":"Meyer","sequence":"additional","affiliation":[{"name":"IV Ensure, Inc , Dallas, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7274-5453","authenticated-orcid":false,"given":"Maria","family":"Alkozah","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Oklahoma Health Campus , Oklahoma City, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Salvaggio","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Oklahoma Health Campus , Oklahoma City, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan P","family":"White","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, OU Health , Oklahoma City, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Siddique","sequence":"additional","affiliation":[{"name":"Department of Medicine, OU Health Edmond Medical Center , Edmond, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1660-5528","authenticated-orcid":false,"given":"Sharanjeet","family":"Thind","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Oklahoma Health Campus , Oklahoma City, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8033-7521","authenticated-orcid":false,"given":"Dale W","family":"Bratzler","sequence":"additional","affiliation":[{"name":"Hudson College of Public Health, University of Oklahoma Health Campus , Oklahoma City, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8730-8929","authenticated-orcid":false,"given":"Joseph","family":"Sassine","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Oklahoma Health Campus , Oklahoma City, Oklahoma ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"2026052019231209000_ciag009-B1","first-page":"20499361231181486","article-title":"From sea to shining IV: the current state of OPAT in the United States","volume":"10","author":"Larnard","year":"2023","journal-title":"Ther Adv Infect Dis"},{"key":"2026052019231209000_ciag009-B2","volume-title":"Handbook of outpatient parenteral antimicrobial therapy for infectious diseases.","author":"Shah","year":"2016","edition":"3rd ed"},{"key":"2026052019231209000_ciag009-B3","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1086\/653520","article-title":"Outpatient parenteral antimicrobial therapy today","volume":"51(suppl 2)","author":"Paladino","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2026052019231209000_ciag009-B4","first-page":"20499361231210353","article-title":"Facilitating OPAT in rural areas","volume":"10","author":"Mehta","year":"2023","journal-title":"Ther Adv Infect Dis"},{"key":"2026052019231209000_ciag009-B5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/1357633X221131842","article-title":"Effectiveness of telemedicine in outpatient parenteral antimicrobial therapy (tele-OPAT): a systematic review","volume":"30","author":"Durojaiye","year":"2024","journal-title":"J Telemed Telecare"},{"key":"2026052019231209000_ciag009-B6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/cid\/ciaf146","article-title":"Quantifying and financing the nonbillable workload of outpatient parenteral antimicrobial therapy (OPAT)\u2014a model for assessing and supporting staffing needs for OPAT programs","volume":"80","author":"Yamshchikov","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026052019231209000_ciag009-B7","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/phar.1799","article-title":"Predictors of hospital readmission in patients receiving outpatient parenteral antimicrobial therapy","volume":"36","author":"Means","year":"2016","journal-title":"Pharmacotherapy"},{"key":"2026052019231209000_ciag009-B8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40360-018-0240-3","article-title":"Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study","volume":"19","author":"Huang","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"key":"2026052019231209000_ciag009-B9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/cid\/cit920","article-title":"Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy","volume":"58","author":"Allison","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026052019231209000_ciag009-B10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/cid\/ciz073","article-title":"Early infectious disease outpatient follow-up of outpatient parenteral antimicrobial therapy patients reduces 30-day readmission","volume":"69","author":"Saini","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026052019231209000_ciag009-B11","doi-asserted-by":"crossref","first-page":"905.e1","DOI":"10.1016\/j.cmi.2018.11.009","article-title":"Developing a risk prediction model for 30-day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy","volume":"25","author":"Durojaiye","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2026052019231209000_ciag009-B12","first-page":"20499361231195966","article-title":"An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy","volume":"10","author":"Bradley","year":"2023","journal-title":"Ther Adv Infect Dis"},{"key":"2026052019231209000_ciag009-B13","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s40121-025-01182-7","article-title":"Risk factors for hospital readmission following outpatient parenteral antimicrobial therapy (OPAT)","volume":"14","author":"Yousif","year":"2025","journal-title":"Infect Dis Ther"},{"key":"2026052019231209000_ciag009-B14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cid\/cix733","article-title":"Rates of and risk factors for adverse drug events in outpatient parenteral antimicrobial therapy","volume":"66","author":"Keller","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026052019231209000_ciag009-B15","doi-asserted-by":"crossref","first-page":"ofx097","DOI":"10.1093\/ofid\/ofx097","article-title":"Bundle in the Bronx: impact of a transition-of-care outpatient parenteral antibiotic therapy bundle on all-cause 30-day hospital readmissions","volume":"4","author":"Madaline","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2026052019231209000_ciag009-B16","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/jac\/dky294","article-title":"Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates","volume":"73","author":"Mansour","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2026052019231209000_ciag009-B17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/jac\/dkt303","article-title":"Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme","volume":"69","author":"Huck","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2026052019231209000_ciag009-B18","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/jac\/dky133","article-title":"Emergency department visits during outpatient parenteral antimicrobial therapy: a retrospective cohort study","volume":"73","author":"Shrestha","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2026052019231209000_ciag009-B19","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1017\/ash.2025.171","article-title":"Healthcare utilization and outcomes of patients discharged to skilled nursing facilities on parenteral antimicrobial therapy","volume":"5","author":"Langenstroer","year":"2025","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2026052019231209000_ciag009-B20","doi-asserted-by":"crossref","first-page":"ofae190","DOI":"10.1093\/ofid\/ofae190","article-title":"Outpatient parenteral antimicrobial therapy in a safety net hospital: opportunities for improvement","volume":"11","author":"Bouzigard","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026052019231209000_ciag009-B21","doi-asserted-by":"crossref","first-page":"ofaa205","DOI":"10.1093\/ofid\/ofaa205","article-title":"Perspectives of patients on outpatient parenteral antimicrobial therapy: experiences and adherence","volume":"7","author":"Hamad","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2026052019231209000_ciag009-B22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/1060028018765159","article-title":"Cost of prescription drug-related morbidity and mortality","volume":"52","author":"Watanabe","year":"2018","journal-title":"Ann Pharmacother"},{"key":"2026052019231209000_ciag009-B23","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/jama.2018.19271","article-title":"Interventions to improve medication adherence: a review","volume":"320","author":"Kini","year":"2018","journal-title":"JAMA"},{"key":"2026052019231209000_ciag009-B24","doi-asserted-by":"crossref","first-page":"104037","DOI":"10.1016\/j.ijnurstu.2021.104037","article-title":"Electronic adherence monitoring devices for children with asthma: a systematic review and meta-analysis of randomised controlled trials","volume":"122","author":"Lee","year":"2021","journal-title":"Int J Nurs Stud"},{"key":"2026052019231209000_ciag009-B25","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/ckj\/sfab111","article-title":"The utility of remote patient management in peritoneal dialysis","volume":"14","author":"Yeter","year":"2021","journal-title":"Clin Kidney J"},{"key":"2026052019231209000_ciag009-B26","doi-asserted-by":"crossref","first-page":"e2400148","DOI":"10.1200\/CCI-24-00148","article-title":"Development and validation of emoji response scales for assessing patient-reported outcomes","volume":"9","author":"Thompson","year":"2025","journal-title":"JCO Clin Cancer Inform"},{"key":"2026052019231209000_ciag009-B27","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1017\/ash.2023.524","article-title":"Impact of a pharmacist-managed outpatient parenteral antimicrobial therapy (OPAT) service on cost savings and clinical outcomes at an academic medical center\u2014ADDENDUM","volume":"3","author":"Epperson","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2026052019231209000_ciag009-B28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jclinepi.2013.08.015","article-title":"Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects","volume":"67","author":"McCambridge","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"2026052019231209000_ciag009-B29","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s10461-014-0905-x","article-title":"The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: findings from the MACH14 study","volume":"18","author":"Simoni","year":"2014","journal-title":"AIDS Behav"},{"key":"2026052019231209000_ciag009-B30","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1291\/hypres.31.2037","article-title":"Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators","volume":"31","author":"Zeller","year":"2008","journal-title":"Hypertens Res"},{"key":"2026052019231209000_ciag009-B31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","article-title":"Self-report measures of medication adherence behavior: recommendations on optimal use","volume":"5","author":"Stirratt","year":"2015","journal-title":"Transl Behav Med"},{"key":"2026052019231209000_ciag009-B32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-5908-3-36","article-title":"Healthcare professionals' intentions and behaviours: a systematic review of studies based on social cognitive theories","volume":"3","author":"Godin","year":"2008","journal-title":"Implement Sci"},{"key":"2026052019231209000_ciag009-B33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ypmed.2004.04.045","article-title":"Patient knows best: blinded assessment of nonadherence with antituberculous therapy by physicians, nurses, and patients compared with urine drug levels","volume":"40","author":"Macintyre","year":"2005","journal-title":"Prev Med"},{"key":"2026052019231209000_ciag009-B34","first-page":"436","article-title":"Adherence to treatment in asthma and COPD patients in their doctors' assessment","volume":"83","author":"Kardas","year":"2015","journal-title":"Pneumonol Alergol Pol"},{"key":"2026052019231209000_ciag009-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1525-1497.2002.09004.x","article-title":"How well do clinicians estimate patients' adherence to combination antiretroviral therapy?","volume":"17","author":"Miller","year":"2002","journal-title":"J Gen Intern Med"},{"key":"2026052019231209000_ciag009-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.03.003","article-title":"Osteoporosis medication adherence: physician perceptions vs. patients' utilization","volume":"55","author":"Curtis","year":"2013","journal-title":"Bone"},{"key":"2026052019231209000_ciag009-B37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1742-1241.2012.02918.x","article-title":"Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians' perceptions of adherence vs. pharmacy claims","volume":"66","author":"Stephenson","year":"2012","journal-title":"Int J Clin Pract"},{"key":"2026052019231209000_ciag009-B38","doi-asserted-by":"crossref","first-page":"ofab418","DOI":"10.1093\/ofid\/ofab418","article-title":"Vancomycin or daptomycin for outpatient parenteral antibiotic therapy: does it make a difference in patient satisfaction?","volume":"8","author":"Wu","year":"2021","journal-title":"Open Forum Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag009\/66301308\/ciag009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/5\/e899\/66301308\/ciag009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/5\/e899\/66301308\/ciag009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:23:22Z","timestamp":1779319402000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/5\/e899\/8416939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,1,8]]},"published-print":{"date-parts":[[2026,5,20]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag009","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,15]]},"published":{"date-parts":[[2026,1,8]]}}}